Sundi Anita, Roopa Nilamber, Gupta Piyalee, Irfan Sana, Kar Tarun Kumar
Department of Microbiology, Virus Research Diagnostic Laboratory, Mahatma Gandhi Memorial Medical College, Jamshedpur, Jharkhand, India.
J Family Med Prim Care. 2024 Sep;13(9):4066-4070. doi: 10.4103/jfmpc.jfmpc_259_24. Epub 2024 Sep 11.
The Human Cytomegalovirus (HCMV) is a type of beta herpesvirus widespread in all human populations. It is estimated that up to 80-100% of adults worldwide and most infections are harmless and can cause severe health complications in infants, like hearing loss and developmental issues. Still, immunocompromised individuals can experience serious complications from the virus. Unfortunately, there is limited information on the prevalence of this virus in our country, and no studies have been reported on the rate of CMV transmission yet.
This study aims to evaluate the levels of IgM antibodies against Cytomegalovirus (CMV) in East Singhbhum, West Singhbhum, and Seraikela Kharsawan using an ELISA test.
An indirect ELISA test was performed to detect anti-CMV IgM and the period of study was from January'2021 to June'2023.
The examination tested 55 people for the TORCH profile of CMV parameters from regions of East Singhbhum, West Singhbhum, and Seraikela Kharsawan. Here, 17 people (30.09%) were IgM positive by ELISA.
The serological data confirms that CMV is not being monitored and recognized in the general population, which limits our study between CMV infection, disease, and clinically diagnosed outcomes. This understanding is crucial for the healthcare and policy sectors. Thus, we recommend implementing a surveillance and mindfulness program for at least one-fourth of the population in Jharkhand and continuing to explore and develop effective vaccines to control CMV infections.
人类巨细胞病毒(HCMV)是一种β疱疹病毒,在所有人群中广泛传播。据估计,全球高达80%-100%的成年人感染过该病毒,且大多数感染是无害的,但在婴儿中可能会导致严重的健康并发症,如听力丧失和发育问题。此外,免疫功能低下的个体可能会因该病毒而出现严重并发症。不幸的是,我国关于这种病毒流行率的信息有限,且尚未有关于CMV传播率的研究报告。
本研究旨在通过酶联免疫吸附测定(ELISA)试验评估东辛格布姆、西辛格布姆和塞赖凯拉哈尔萨万地区针对巨细胞病毒(CMV)的IgM抗体水平。
采用间接ELISA试验检测抗CMV IgM,研究期间为2021年1月至2023年6月。
对来自东辛格布姆、西辛格布姆和塞赖凯拉哈尔萨万地区的55人进行了CMV参数的TORCH检测。其中,17人(30.09%)ELISA检测IgM呈阳性。
血清学数据证实,普通人群中未对CMV进行监测和识别,这限制了我们对CMV感染、疾病和临床诊断结果之间关系的研究。这种认识对医疗保健和政策部门至关重要。因此,我们建议在恰尔肯德邦至少四分之一的人口中实施监测和宣传计划,并继续探索和开发有效的疫苗来控制CMV感染。